Literature DB >> 21965700

Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.

Matthew L Stoll, Marilynn Punaro, Ashish S Patel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965700      PMCID: PMC3586818          DOI: 10.3899/jrheum.110508

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  9 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

2.  Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.

Authors:  S K Bunn; W M Bisset; M J Main; B E Golden
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-02       Impact factor: 2.839

Review 3.  Magnetic resonance imaging in Crohn's disease.

Authors:  Rakesh Sinha; Chuka Nwokolo; Paul D Murphy
Journal:  BMJ       Date:  2008-02-02

4.  pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.

Authors:  Mirjam de Vries; Irene van der Horst-Bruinsma; Ingrid van Hoogstraten; Adriaan van Bodegraven; B Mary E von Blomberg; Mary von Blomberg; Hana Ratnawati; Ben Dijkmans
Journal:  J Rheumatol       Date:  2010-09-01       Impact factor: 4.666

5.  Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study.

Authors:  H Mielants; E M Veys; C Cuvelier; M De Vos; S Goemaere; M Maertens; R Joos
Journal:  J Rheumatol       Date:  1993-09       Impact factor: 4.666

6.  High prevalence of NSAID enteropathy as shown by a simple faecal test.

Authors:  J A Tibble; G Sigthorsson; R Foster; D Scott; M K Fagerhol; A Roseth; I Bjarnason
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

7.  Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

Authors:  F Costa; M G Mumolo; M Bellini; M R Romano; L Ceccarelli; P Arpe; C Sterpi; S Marchi; G Maltinti
Journal:  Dig Liver Dis       Date:  2003-09       Impact factor: 4.088

8.  Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.

Authors:  H Mielants; E M Veys; S Goemaere; K Goethals; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

9.  The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.

Authors:  H Mielants; E M Veys; C Cuvelier; M De Vos; S Goemaere; L De Clercq; L Schatteman; L Gyselbrecht; D Elewaut
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

  9 in total
  18 in total

1.  Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report.

Authors:  Lillemor Berntson
Journal:  Clin Rheumatol       Date:  2014-05-23       Impact factor: 2.980

Review 2.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

3.  Identification of Prevotella Oralis as a possible target antigen in children with Enthesitis related arthritis.

Authors:  Matthew L Stoll; L Wayne Duck; Margaret H Chang; Robert A Colbert; Peter A Nigrovic; Susan D Thompson; Charles O Elson
Journal:  Clin Immunol       Date:  2020-05-11       Impact factor: 3.969

Review 4.  [Spondyloarthritis in childhood and adulthood].

Authors:  Toni Hospach; Gerd Horneff; Denis Poddubnyy
Journal:  Z Rheumatol       Date:  2022-01-05       Impact factor: 1.372

5.  Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN).

Authors:  Lillemor Berntson; Peter Agback; Johan Dicksved
Journal:  Clin Rheumatol       Date:  2016-03-29       Impact factor: 2.980

Review 6.  Advances in Juvenile Spondyloarthritis.

Authors:  Hemalatha Srinivasalu; Erin Brennan Treemarcki; Christopher Redmond
Journal:  Curr Rheumatol Rep       Date:  2021-07-13       Impact factor: 4.592

7.  Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.

Authors:  Judith Pichler; Christina Ong; Neil Shah; Neil Sebire; Fevronia Kiparrissi; Osvaldo Borrelli; Clarissa Pilkington; Mamoun Elawad
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

Review 8.  The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Authors:  Matthew L Stoll; Randy Q Cron
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 9.  Update on juvenile spondyloarthritis.

Authors:  Anusha Ramanathan; Hemalatha Srinivasalu; Robert A Colbert
Journal:  Rheum Dis Clin North Am       Date:  2013-08-24       Impact factor: 2.670

Review 10.  Calprotectin: Clinical Applications in Pediatrics.

Authors:  Oscar R Herrera; Michael L Christensen; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.